Three Undeclared Drug Ingredients Detected in a Dietary Supplement: How Can Brand Buyers Verify Formula Authenticity?
Supplier formula records and finished-product testing must corroborate each other
Undeclared active ingredients change the nature of a product
Buyers cannot check label ingredients alone. High-risk supplements need independent screening to identify their ingredients.
On October 24, 2026, the FDA announced a recall of Ultimate Forza male supplements. Undeclared sildenafil, tadalafil, and dapoxetine were detected across all lots. The first two ingredients may interact with nitrate medicines and cause dangerously low blood pressure.
Buyers need to verify four areas
| Area | What to check | Warning signs |
|---|---|---|
| Formula | Ingredient names and quantities | Vaguely described proprietary blends |
| Raw materials | Identity, purity, and suppliers | Sources cannot be traced |
| Finished products | Targeted screening and analytical fingerprints | Unusually strong effects |
| Sales channels | Claims and complaints | Drug-like promises |
Third-party testing needs suitable methods
Routine nutritional testing may not detect illegal drugs. Buyers should choose targeted screening and unknown-substance analysis based on the risks of the product category.
Supplier audits should trace raw-material sources
Brand owners should review raw-material purchase orders, lot numbers, retained samples, and actual production records. Formula changes must be approved.
Scope and limits
This article applies to dietary supplement brands and importers. Markets have different rules for ingredients, claims, and product classification. Businesses should obtain regulatory and laboratory support.
FAQ
1. Is a factory-issued COA enough?
No. Buyers need to confirm that the COA is authentic, uses suitable methods, and matches the actual lot.
2. Does every lot need screening for illegal drugs?
The frequency should depend on the product category, supplier, and risk history. High-risk categories need stronger controls.
3. Can sales continue if no adverse events have been reported?
No. Undeclared drug ingredients already present a serious compliance risk.
Use independent data to verify supplier statements
Brand buyers should connect the formula, raw materials, and finished-product testing and retain lot-level evidence.
Formula authenticity cannot depend on trust alone. It needs repeatable laboratory evidence.
How stellar.shop can support buyers
stellar.shop can help buyers organize requirements for raw-material identity, quality systems, testing, and change control and compare supplement suppliers' documentation.